Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from BofA Securities

Why This Analyst Believes In Credo Technology

Credo Technology Group Holding Ltd (NASDAQ: CRDO) is an emerging cloud networking specialist that estimates its addressable market to grow at a compounded annual growth rate (CAGRA) of nearly 49%, according to BofA Securities.

Benzinga

Why BofA Loves This Digital Advertising Platform Company

Although AdTheorent Holding Company Inc (NASDAQ: ADTH) is a smaller player in the competitive digital advertising space, there is long-term opportunity as its target addressable market is expected to grow more than 20% for the next several years, according to BofA Securities.

Benzinga

BofA Downgrades Core & Main On What Near-Term Headwinds?

Core & Main Inc (NYSE: CNM) is likely to be impacted by a minimal increase in spending in 2022 with delays in project starts, according to BofA Securities.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Why BofA Upgrades Lending Platform Upstart Holdings After Q4 Report

Upstart Holdings Inc (NASDAQ: UPST) was able to beat fourth-quarter expectations despite industry headwinds, according to BofA Securities.

Benzinga

BofA Downgrades ViacomCBS After Streaming Investments: What Investors Need To Know

Although ViacomCBS Inc (NASDAQ: VIAC) remains an attractive target amid industry consolidation, a sale of the company is unlikely in the near term given its streaming aspirations, according to BofA Securities.

Benzinga

BofA Maintains Underperform Rating As Virgin Galactic Begins Selling Space Flight Tickets

Virgin Galactic Holdings Inc (NYSE: SPCE) has announced the opening of space flight ticket sales to the public on Feb. 16. Reservations are being offered at $450,000, with an initial deposit of $150,000, according to BofA Securities.

Benzinga

BofA Downgrades Gap On Old Navy Concerns

Old Navy, which contributes to around 55% of Gap Inc’s (NYSE: GPS) sales, is likely to be “disproportionately hurt” by its exposure to low-income consumers and worsening supply chain disruptions, according to BofA Securities.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

BofA Upgrades DTE Energy After Beat, Says Company Has Among Best Earnings Growth In Sector

DTE Energy Co (NYSE: DTE) reported its fiscal 2021 results ahead of expectations, raised its 2022 earnings guidance range and provided a “strong affirmation of the long-term growth trajectory,” according to BofA Securities.

Benzinga

Why This Bullish SoFi Analyst Sees Growth Ahead

SoFi Technologies Inc (NASDAQ: SOFI) is poised to generate strong revenue and EBITDA growth driven by its Galileo platform and member growth initiatives, according to BofA Securities.

Benzinga

TPG Has A High Growth Trajectory, BofA Says With Buy Rating: What Else Impressed The Analyst?

TPG Inc (NASDAQ: TPG) has a robust business model, which is high growth, capital light and drives fee-related earnings, according to BofA Securities. The TPG Analyst: Craig Siegenthaler initiated coverage of TPG with a Buy rating and a price target of $47.

Benzinga

BofA Downgrades Southern Company, Sees Little Upside From Solar

There are concerns around how much of Georgia Power’s Integrated Resource Plan (IRP) that Southern Co (NYSE: SO) can win versus unrelated third parties, according to BofA Securities.

Benzinga

BofA Downgrades First Solar On Potential Margin Pressure

The Section 201 Solar tariffs on bifacial panels will probably not be extended, which could potentially erode First Solar, Inc’s (NASDAQ: FSLR) pricing power, according to BofA Securities.

Benzinga

Why This Analyst Believes Ameresco Is Oversold

While Ameresco Inc.’s (NYSE: AMRC) shares are down due to the disappointing BBB legislative and rates, as well as leverage factors and concerns around its delayed Analyst Day, according to BofA Securities the company offers “superior EBITDA growth (high-teens)” and the potential of a po

Benzinga

BofA Downgrades Ionis After Vupanorsen Setback: Are There Upcoming Catalysts That Can Help The Stock?

Ionis Pharmaceuticals Inc (NASDAQ: IONS) announced on Monday the discontinuation of the Vupanorsen clinical development program. Following this, there are no high-impact catalysts for the next 12 months that could unlock value, according to BofA Securities.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Carnival Extends Time For Equity Offering

Carnival Corp (NYSE:CCL) has extended its share purchase program until April 30, 2022, under the same terms, from the previous date of January 31, 2022. The company had offered to sell shares of its common stock through its agent BofA Securities, having an aggregate offering price of up to $500 million. As announced…

Benzinga

Why This Crescent Capital BDC Analyst Is Bullish

Crescent Capital BDC Inc (NASDAQ: CCAP) has been gaining share in the middle market, where demand for capital “remains robust,” according to BofA Securities.

Benzinga

Why BofA Sees 'Better Entry Point' In Ginkgo Bioworks Stock

Ginkgo Bioworks Holdings Inc (NYSE: DNA) is “at the forefront of the rising SynBio wave, a market we think holds much long-term promise,” according to BofA Securities.

Benzinga

BofA Expecting Earnings Beat From GM, But Misses From Ford And Tesla: What Investors Need To Know

Although expectations in the automotive industry have been “set reasonably low” heading into the quarter, investors are likely to focus on outlooks for 2022 and beyond, according to BofA Securities.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Why This BofA Securities Analyst Is Cutting Airline Price Targets

The underlying fundamentals in the airline sector remain challenging. Against this backdrop, investors should focus on quality names such as Delta Air Lines, Inc.

Benzinga

5 Reasons Blue Owl Capital Should Generate Strong Earnings Growth

Although Blue Owl Capital Inc.’s (NYSE: OWL) stock has been underperforming, the company enjoys a high-growth, high-margin and capital-light business, according to BofA Securities.

Benzinga

Why This Analyst Has Increased Confidence In Inovio Pharmaceuticals

Following the recent pullback in Inovio Pharmaceuticals Inc.’s (NASDAQ: INO) shares, the stock valuation seems to have been stripped of most of the remaining COVID-19 value, according to BofA Securities.

Benzinga

BofA Downgrades CureVac On Limited 2022 Prospects

There is limited upside from CureVac BV’s (NASDAQ: CVAC) COVID-19 vaccine and there are few catalysts from the rest of the company’s pipeline in 2022, according to BofA Securities.

Benzinga

Why BofA Upgrades CH Robinson Worldwide

Brokerage carriers such as CH Robinson Worldwide Inc (NASDAQ: CHRW) are poised to benefit from continued strength in contract rates in the first half of 2022 and the subsequent “roll over as fluidity improves in the supply chain,” according to BofA Securities.

Benzinga

Why This Analyst Is Worried About Opendoor's iBuying Model In 2022

While Opendoor Technologies Inc (NASDAQ: OPEN) had strong revenues and increasing potential to gain market share, the iBuying model is “inherently risky, low margin, and capital intensive,” according to BofA Securities.

Benzinga

Why This Tesla Analyst Is Projecting Sharp Drop In Market Share, Benefits For Legacy Automakers

Tesla, Inc. (NASDAQ: TSLA), which has a commanding position in the U.S. electric vehicle market, could see an erosion in market share in the medium term, according to a BofA Securities analyst.

1 … 6 7 8 9

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Places

United States

406,393 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.